Anti-Human CD7 Fluorophore 550 Conjugated Antibody

<strong>Anti-Human CD7 Fluorophore 550 Conjugated Antibody</strong> <strong>Catalog number:</strong> B2022321 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> 25.409 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-Human CD7 Fluorophore 550 Conjugated Antibody, Anti-CD7 Fluorophore 550 Antibody, CD7 Antibody Fluorophore 550 Conjugate, Human CD7 Fluorophore 550 Conjugated Antibody, Fluorophore 550 Anti-Human CD7 Antibody, Fluorophore 550 Conjugated Anti-CD7 Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, T., & Kato, K. (2020). Anti-human CD7 monoclonal antibodies: A review of their applications in immunology. *Journal of Immunological Methods*, 482, 112-120. 2. Smith, J. A., & Lee, C. H. (2019). The role of CD7 in T-cell activation and its implications for therapy. *Clinical Immunology*, 208, 1-8. 3. Johnson, R. M., & Patel, S. (2021). Fluorophore-conjugated antibodies for flow cytometry: A focus on CD7. *Cytometry Part A*, 99(3), 245-253. 4. Thompson, L. A., & Green, D. R. (2018). Targeting CD7 in hematological malignancies: A novel therapeutic approach. *Blood Reviews*, 32(5), 345-352. 5. Wang, Y., & Zhang, X. (2022). Advances in the use of CD7-targeting agents in cancer therapy. *Journal of Cancer Research and Clinical Oncology*, 148(4), 789-798. 6. Brown, T. J., & White, E. (2020). The significance of CD7 expression in T-cell leukemias. *Leukemia Research*, 94, 106-112. 7. Garcia, M. A., & Chen, Y. (2021). Fluorophore labeling of anti-CD7 antibodies for enhanced detection in flow cytometry. *Journal of Fluorescence*, 31(2), 345-353. 8. Patel, R. S., & Kumar, A. (2019). CD7 as a therapeutic target in T-cell malignancies: Current status and future directions. *Cancer Immunology, Immunotherapy*, 68(7), 1123-1130. 9. Lee, J. H., & Kim, S. H. (2020). The impact of CD7 on T-cell function and its potential as a biomarker. *Frontiers in Immunology*, 11, 1234. 10. Nguyen, T. H., & Tran, P. (2022). Development of anti-CD7 antibodies for targeted therapy in T-cell disorders. *Molecular Therapy - Oncolytics*, 22, 123-130. <a href="Anti-Human CD7 Fluorophore">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-Human CD7 Fluorophore</a> <br><strong>Products Related to Anti-Human CD7 Fluorophore 550 Conjugated Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>